136 related articles for article (PubMed ID: 22307210)
1. Transperineal template-guided mapping biopsy as a staging procedure to select patients best suited for active surveillance.
Taira AV; Merrick GS; Bennett A; Andreini H; Taubenslag W; Galbreath RW; Butler WM; Bittner N; Adamovich E
Am J Clin Oncol; 2013 Apr; 36(2):116-20. PubMed ID: 22307210
[TBL] [Abstract][Full Text] [Related]
2. Transperineal Template-guided Mapping Biopsy Identifies Pathologic Differences Between Very-Low-risk and Low-risk Prostate Cancer: Implications for Active Surveillance.
Merrick GS; Delatore A; Butler WM; Bennett A; Fiano R; Anderson R; Adamovich E
Am J Clin Oncol; 2017 Feb; 40(1):53-59. PubMed ID: 25068472
[TBL] [Abstract][Full Text] [Related]
3. Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy.
Lee CU; Sung SH; Jang CT; Kang M; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
Urol Int; 2019; 103(3):262-269. PubMed ID: 31269509
[TBL] [Abstract][Full Text] [Related]
4. Clinical performance of transperineal template guided mapping biopsy for therapeutic decision making in low risk prostate cancer.
Ahallal Y; Sanchez-Salas R; Sivaraman A; Barret E; Secin FP; Validire P; Rozet F; Galiano M; Cathelineau X
Actas Urol Esp; 2016 Dec; 40(10):615-620. PubMed ID: 27527686
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Performance of Initial Transperineal Template-guided Mapping Biopsy of the Prostate Gland.
Bittner N; Merrick GS; Bennett A; Butler WM; Andreini HJ; Taubenslag W; Adamovich E
Am J Clin Oncol; 2015 Jun; 38(3):300-3. PubMed ID: 23764680
[TBL] [Abstract][Full Text] [Related]
6. Location and Grade of Prostate Cancer Diagnosed by Transperineal Template-guided Mapping Biopsy After Negative Transrectal Ultrasound-guided Biopsy.
Bittner N; Merrick G; Taira A; Bennett A; Schattel A; Butler W; Galbreath R; Adamovich E
Am J Clin Oncol; 2018 Aug; 41(8):723-729. PubMed ID: 27906722
[TBL] [Abstract][Full Text] [Related]
7. Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostate.
Bittner N; Merrick GS; Stewart R; Andreini H; Taubenslag W; Curtis R; Butler WM; Wallner KE
Urol Oncol; 2011; 29(4):398-404. PubMed ID: 19945303
[TBL] [Abstract][Full Text] [Related]
8. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy.
Bittner N; Merrick GS; Butler WM; Bennett A; Galbreath RW
J Urol; 2013 Aug; 190(2):509-14. PubMed ID: 23416641
[TBL] [Abstract][Full Text] [Related]
9. Incidence, grade and distribution of prostate cancer following transperineal template-guided mapping biopsy in patients with atypical small acinar proliferation.
Merrick GS; Galbreath RW; Bennett A; Butler WM; Amamovich E
World J Urol; 2017 Jul; 35(7):1009-1013. PubMed ID: 27900453
[TBL] [Abstract][Full Text] [Related]
10. Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance?
Chen DJ; Falzarano SM; McKenney JK; Przybycin CG; Reynolds JP; Roma A; Jones JS; Stephenson A; Klein E; Magi-Galluzzi C
BJU Int; 2015 Aug; 116(2):220-9. PubMed ID: 25060664
[TBL] [Abstract][Full Text] [Related]
11. Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound-guided biopsy: the Victorian Transperineal Biopsy Collaboration experience.
Ong WL; Weerakoon M; Huang S; Paul E; Lawrentschuk N; Frydenberg M; Moon D; Murphy D; Grummet J
BJU Int; 2015 Oct; 116(4):568-76. PubMed ID: 25560926
[TBL] [Abstract][Full Text] [Related]
12. Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB.
Bittner N; Merrick GS; Andreini H; Taubenslag W; Allen ZA; Butler WM; Anderson RL; Adamovich E; Wallner KE
Urology; 2009 Jul; 74(1):171-6. PubMed ID: 19232691
[TBL] [Abstract][Full Text] [Related]
13. Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting.
Taira AV; Merrick GS; Galbreath RW; Andreini H; Taubenslag W; Curtis R; Butler WM; Adamovich E; Wallner KE
Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):71-7. PubMed ID: 19786982
[TBL] [Abstract][Full Text] [Related]
14. The morbidity of transperineal template-guided prostate mapping biopsy.
Merrick GS; Taubenslag W; Andreini H; Brammer S; Butler WM; Adamovich E; Allen Z; Anderson R; Wallner KE
BJU Int; 2008 Jun; 101(12):1524-9. PubMed ID: 18325064
[TBL] [Abstract][Full Text] [Related]
15. The role of a standardized 36 core template-assisted transperineal prostate biopsy technique in patients with previously negative transrectal ultrasonography-guided prostate biopsies.
Pal RP; Elmussareh M; Chanawani M; Khan MA
BJU Int; 2012 Feb; 109(3):367-71. PubMed ID: 21883818
[TBL] [Abstract][Full Text] [Related]
16. [Pelvic MRI combined with TRUS-guided transperineal template mapping biopsy for the diagnosis of prostate cancer].
Li Q; Xie JJ; Cao WZ; Deng JP; Liu C; Cui Y; Shao Q; Shen H
Zhonghua Nan Ke Xue; 2019 May; 25(5):408-413. PubMed ID: 32216225
[TBL] [Abstract][Full Text] [Related]
17. Transrectal ultrasound-guided transperineal 14-core systematic biopsy detects apico-anterior cancer foci of T1c prostate cancer.
Kawakami S; Kihara K; Fujii Y; Masuda H; Kobayashi T; Kageyama Y
Int J Urol; 2004 Aug; 11(8):613-8. PubMed ID: 15285751
[TBL] [Abstract][Full Text] [Related]
18. Combination of multiparametric MRI and transperineal template-guided mapping biopsy of the prostate to identify candidates for hemi-ablative focal therapy.
Tran M; Thompson J; Böhm M; Pulbrook M; Moses D; Shnier R; Brenner P; Delprado W; Haynes AM; Savdie R; Stricker PD
BJU Int; 2016 Jan; 117(1):48-54. PubMed ID: 25682968
[TBL] [Abstract][Full Text] [Related]
19. Higher percentage of positive biopsy cores and Gleason score are associated with a greater degree of prostate gland shrinkage after neoadjuvant cytoreductive therapy.
Bittner N; Merrick GS; Butler WM; Galbreath RW; Anderson RL; Adamovich E; Wallner KE
Brachytherapy; 2012; 11(3):219-23. PubMed ID: 21820364
[TBL] [Abstract][Full Text] [Related]
20. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
